Anne Bastian

1.1k total citations
12 papers, 895 citations indexed

About

Anne Bastian is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Anne Bastian has authored 12 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Anne Bastian's work include Immunotherapy and Immune Responses (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Biochemical and Molecular Research (3 papers). Anne Bastian is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Biochemical and Molecular Research (3 papers). Anne Bastian collaborates with scholars based in United States. Anne Bastian's co-authors include Jeffrey Schlom, William L. Dahut, Philip M. Arlen, Seth M. Steinberg, James L. Gulley, Alice P. Chen, J. Michael Hamilton, Jennifer L. Marté, Patricia K. Beetham and C. Norman Coleman and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Anne Bastian

12 papers receiving 867 citations

Peers

Anne Bastian

IMMUN

ONCOL

MB

PRM

PFM

Klaus Fenchel Germany

Janet Ayello United States

Ayse U. Akarca United Kingdom

Stefan Störkel Germany

Daniel R. Vlock United States

G Risdon United States

Jörg Westermann Germany

MF Martelli Italy

Catherine Genevée France

S Jagannath United States

Klaus Fenchel Germany

Anne Bastian

287 ×0.5

IMMUN

340 ×0.7

ONCOL

258 ×1.0

MB

164 ×0.8

PRM

109 ×0.8

PFM

Citations per year, relative to Anne Bastian Anne Bastian (= 1×) peers Klaus Fenchel

Countries citing papers authored by Anne Bastian

Since Specialization

Citations

This map shows the geographic impact of Anne Bastian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Bastian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Bastian more than expected).

Fields of papers citing papers by Anne Bastian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Bastian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Bastian. The network helps show where Anne Bastian may publish in the future.

Co-authorship network of co-authors of Anne Bastian

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Bastian. A scholar is included among the top collaborators of Anne Bastian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Bastian. Anne Bastian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Gulley, James L., Philip M. Arlen, Anne Bastian, et al.. (2005). Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer. Clinical Cancer Research. 11(9). 3353–3362. 280 indexed citations

2.

Arlen, Philip M., James L. Gulley, Ronald Lieberman, et al.. (2005). ANTIANDROGEN, VACCINE AND COMBINATION THERAPY IN PATIENTS WITH NONMETASTATIC HORMONE REFRACTORY PROSTATE CANCER. The Journal of Urology. 174(2). 539–546. 86 indexed citations

3.

Gulley, James L., Alice P. Chen, William L. Dahut, et al.. (2002). Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV‐PSA) in patients with metastatic androgen‐independent prostate cancer. The Prostate. 53(2). 109–117. 175 indexed citations

4.

Khleif, Samir N., Scott I. Abrams, J. Michael Hamilton, et al.. (1999). A Phase I Vaccine Trial with Peptides Reflecting ras Oncogene Mutations of Solid Tumors. Journal of Immunotherapy. 22(2). 155–165. 96 indexed citations

5.

Longo, Dan L., Eli Glatstein, P L Duffey, et al.. (1997). Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.. Journal of Clinical Oncology. 15(11). 3338–3346. 39 indexed citations

6.

Bastian, Anne, et al.. (1997). Dihydropyrimidine dehydrogenase deficiency: a pharmacogenetic defect causing severe adverse reactions to 5-fluorouracil-based chemotherapy.. PubMed. 24(1). 83–8. 32 indexed citations

7.

Politi, Pedro M., William Dahut, Harry Ford, et al.. (1995). Phase I clinical trial of continuous infusion cyclopentenyl cytosine. Cancer Chemotherapy and Pharmacology. 36(6). 513–523. 37 indexed citations

8.

Politi, Pedro M., William Dahut, Harry Ford, et al.. (1995). Phase I clinical trial of continuous infusion cyclopentenyl cytosine. Cancer Chemotherapy and Pharmacology. 36(6). 513–523. 2 indexed citations

9.

Foss, Francine M., Daniel C. Ihde, Ilona Linnoila, et al.. (1994). Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.. Journal of Clinical Oncology. 12(10). 2051–2059. 76 indexed citations

10.

O’Shaughnessy, Joyce, Andrea Denicoff, David Venzon, et al.. (1994). A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients. Annals of Oncology. 5(8). 709–716. 24 indexed citations

11.

Johnson, Bruce E., Robert Parker, Robert H. Shoemaker, et al.. (1993). Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer. Investigational New Drugs. 11(1). 29–37. 6 indexed citations

12.

Longo, Dan L., P L Duffey, Vincent T. DeVita, et al.. (1991). Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.. Journal of Clinical Oncology. 9(8). 1409–1420. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact